The following information was missing from the Competing Interests section: SMK, RWC, and Emory University have equity interests in Zetra Biologicals, which is developing virus-like particle technology under license from Emory University. The authors state that this does not alter their adherence to all the PLoS ONE policies on sharing data and materials.
Citation: Pearton M, Kang S-M, Song J-M, Anstey AV, Ivory M, Compans RW, et al. (2010) Correction: Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines. PLoS ONE 5(11): 10.1371/annotation/00a3b22e-36a9-4d51-89e5-1e6561e7a1e9. https://doi.org/10.1371/annotation/00a3b22e-36a9-4d51-89e5-1e6561e7a1e9
Published: November 03, 2010
Copyright: © . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests: No competing interests declared.